Invesco Nasdaq Biotechnology ETF (IBBQ)

Assets	$65.16M
Expense Ratio	0.19%
PE Ratio	20.66
Shares Out	2.26M
Dividend (ttm)	$0.25
Dividend Yield	0.85%
Ex-Dividend Date	Mar 23, 2026
Payout Frequency	Quarterly
Payout Ratio	17.66%

Volume	20,006
Open	28.74
Previous Close	28.84
Day's Range	28.74 - 29.38
52-Week Low	19.47
52-Week High	30.50
Beta	0.62
Holdings	262
Inception Date	Jun 11, 2021

About IBBQ

Fund Home Page

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is issued by Invesco.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: IBBQ
• ETF Provider: Invesco
• Index Tracked: NASDAQ / Biotechnology

Top 10 Holdings

41.79% of assets

Name	Symbol	Weight
Amgen Inc.	AMGN	7.40%
Gilead Sciences, Inc.	GILD	7.29%
Vertex Pharmaceuticals Incorporated	VRTX	7.14%
Regeneron Pharmaceuticals, Inc.	REGN	5.92%
Alnylam Pharmaceuticals, Inc.	ALNY	3.31%
Insmed Incorporated	INSM	2.37%
Revolution Medicines, Inc.	RVMD	2.30%
Biogen Inc.	BIIB	2.24%
United Therapeutics Corporation	UTHR	2.02%
argenx SE	ARGX	1.79%

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 23, 2026	$0.03609	Mar 27, 2026
Dec 22, 2025	$0.0906	Dec 26, 2025
Sep 22, 2025	$0.09576	Sep 26, 2025
Jun 23, 2025	$0.0287	Jun 27, 2025
Mar 24, 2025	$0.04021	Mar 28, 2025
Dec 23, 2024	$0.06191	Dec 27, 2024

Performance

IBBQ had a total return of 39.30% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.93%.